Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

PurpleLab® is driven by a singular goal – to provide healthcare organizations with robust and accessible real-world data (RWD) and real-world evidence (RWE) to solve conventional and emerging challenges, including tackling medication adherence. According to the FDA[1], real-world evidence (RWE) is defined as “the clinical evidence that looks at the usage and potential benefits or…

The fact that healthcare organizations need to improve care outcomes is undeniably undisputed. To succeed, health plan leaders need to acknowledge that medical care is estimated to account for only 10% to 20% of the modifiable contributors to healthy outcomes for a population. The other 80% to 90% emanates from social determinants of health (SDOH),…

This blog is part four in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Medical affairs is a department within pharmaceutical companies that focuses on communicating scientific and clinical information to healthcare providers. Pharmaceutical medical affairs teams are responsible for activities that bridge the gap between the development…

Amidst the backdrop of evolving privacy regulations and the phasing out of traditional digital identifiers, the video explores the essential strategies pharmaceutical advertisers must adopt to navigate these industry challenges and accurately assess the real-world outcomes they are achieving from their advertising. This is a video recording of a speaking session produced in partnership with…

Pharma brand managers have a data problem: namely, they have access to so much of it that it can inundate their decision-making processes. We outline the best ways of streamlining the volume of information and separating the proverbial wheat from the chaff. This is a video recording of a speaking session produced in partnership with…

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications frequently used to treat type 2 diabetes mellitus (T2DM) and obesity.[1] This class of medications assists in lowering blood sugar levels and promotes weight loss. In addition to treating diabetics, these medications are also used to treat obesity in diabetics as well as non-diabetics.   GLP-1 drugs…

Introduction In today’s highly competitive healthcare marketing industry, marketers need to take a strategic approach to audience development that accounts for the intersection of factors that impact the provider’s ability to treat the patient, the marketer’s capacity to engage the attention of the healthcare provider, and the “knowability” of these factors. Drawing from the work…

PurpleLab® provides a real-world data [lab], accelerating the discovery and adoption of healthcare innovations. View where PurpleLab insights have been leveraged.  Healthcare IT News PurpleLab Introduced Alerts to Help Life Science Organizations Determine When to Engage with Physicians Read Now 6/9/2024 NBC News (Online) Popular Weight Loss Drugs Remain Out of Reach for Many Who…

This blog is part three in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Health Economics and Outcomes Research (HEOR) is a field that determines the cost-effectiveness of drugs, medical devices and other healthcare interventions. It analyzes data from various sources to build evidence around the value of…